Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.
Magnus Medical has raised $64.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Magnus Medical's investors include Red Tree Venture Capital, Jazz Venture Partners.
Magnus Medical is headquartered in Burlingame, United States.
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.
Magnus Medical is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnus Medical — Funding & Investors." VCBacked, March 14, 2025, https://www.vcbacked.co/company/magnus-medical. Accessed September 30, 2026.
VCBacked. (2025). Magnus Medical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/magnus-medical
{{cite web |title=Magnus Medical — Funding & Investors |url=https://www.vcbacked.co/company/magnus-medical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated